Knowledge

Vyera Pharmaceuticals

Source đź“ť

38: 273:
In response to criticisms of the September 2015 price increases, Turing Pharmaceuticals announced various patient affordability and access initiatives and in November 2015 the company reduced the cost of Daraprim for hospitals by up to 50% of the increased rate. Despite these partial rollbacks to
290:, the settlement "requires Vyera and Phoenixus to provide up to $ 40 million in relief over 10 years to consumers who allegedly were fleeced by their actions and requires them to make Daraprim available to any potential generic competitor at the cost of producing the drug." According to 559: 315:
This product, also called TUR-001, is Turing Pharmaceuticals' oxytocin nasal solution. Syntocinon, short for 'synthetic oxytocin', was first introduced by the Swiss pharmaceutical company Sandoz in 1956. The product had gained FDA approval in 1960 to assist in initial
563: 680: 886: 585: 200:. The company was widely criticized for raising the price of daraprim by 5456% following its acquisition of rights to the drug in 2015. The company's stock price dropped around 10% after the price increase of the drug. CEO 660: 285:
In January 2020 the FTC filed a case against Vyera "alleging an elaborate anticompetitive scheme to preserve a monopoly for the life-saving drug, Daraprim". A settlement was reached in December 2021. According to
246:
In September 2015, Turing raised the price of Daraprim from $ 13.50 to $ 750 a tablet. This increase prompted widespread criticism of the company from many quarters, including the pharmaceutical industry itself.
860: 706: 732: 589: 684: 266:, and has been available since 1953. At the time of the Daraprim acquisition Turing Pharmaceuticals indicated that it intended to develop new toxoplasmosis drug candidates with better 890: 279: 482: 927: 864: 710: 508: 328:
the product from Novartis in December 2013 in order to bring it back to the market for postpartum milk ejection as well as look into its use in the treatment of
739: 917: 838: 282:, since Turing's acquisition to the rights in Daraprim, the drug has gone from being affordable and readily available to being prohibitively expensive. 250:
Shkreli resigned as Turing Pharmaceuticals' CEO on 18 December 2015, following his arrest on charges of defrauding investors in his former hedge fund.
797: 922: 637: 433: 533: 763: 560:"Launch of Turing Pharmaceuticals Announced – New Drug Company to Focus on Treating Unmet Medical Needs Across Broad Therapeutic Areas" 612: 818: 294:, Kevin Mulleady "agreed to a seven-year ban on working for or holding more than an 8% share in most pharmaceutical companies." 17: 777: 369: 392:, TRP-004 for toxoplasmosis, TRP-005 for epileptic encephalopathy, and TRP-011 for congenital metabolic disorder. 336:. Turing Pharmaceuticals is preparing for a Phase III in lactation and other indications are planned. 782: 385: 365: 437: 376:. A Phase I Clinical Trial of TUR 004 for epileptic encephalopathies commenced in November 2015. 125: 681:"Turing Pharmaceuticals LLC Announces Improvements in Daraprim Accessibility and Affordability" 887:"Turing Initiates Dosing in Phase I Clinical Trial of TUR 004 for Epileptic Encephalopathies" 325: 212: 661:"CEO who raised price of old pill more than $ 700 calls journalist a 'moron' for asking why" 932: 239:
nasal solution, and Vecamyl. The company acquired the US marketing rights to Daraprim from
181:. The company started to do business in the US as Vyera Pharmaceuticals in September 2017. 8: 665: 586:"Turing Pharmaceuticals AG Acquires U.S. Marketing Rights to DARAPRIM® (pyrimethamine)" 360:
This product is under development for the treatment of seizures associated with severe
240: 757: 349: 274:
the initial price increase, according to February 2, 2016, memo from Representative
459: 408: 275: 58: 48: 204:
faced immense criticism for his actions. The company was previously named after
839:"Retrophin Signs U.S. License Agreement for Syntocinon™ Nasal Spray (Oxytocin)" 483:"Turing Pharma Says Daraprim Availability Will Be Unaffected By Shkreli Arrest" 389: 224: 201: 166: 89: 262:, which is indicated for the treatment of toxoplasmosis in combination with a 911: 329: 259: 189: 185: 178: 102: 197: 193: 344:
This product is Turing Pharmaceuticals' intranasal formulation of racemic
509:"Gadfly Pharma Investor Shkreli Starts Anew After Ousting From Retrophin" 263: 228: 205: 174: 110: 638:"Martin Shkreli resigns from Turing Pharmaceuticals after fraud charges" 819:"Former Shkreli Co. Inks Deal Worth Up To $ 40M With FTC, AGs - Law360" 317: 534:"Convicted pharma fraudster Shkreli's companies file for bankruptcy" 361: 345: 321: 236: 232: 302:
Vecamyl is currently indicated for the treatment of hypertension.
802: 287: 280:
United States House Committee on Oversight and Government Reform
823: 368:
filing for TUR-004 in October 2015 and the product was granted
333: 291: 348:. The company is working on the product for the treatment of 37: 861:"Turing Pharmaceuticals AG Announces IND Filing for TUR-004" 798:"'Pharma Bro' firm reaches $ 40M settlement in gouging case" 267: 231:
developer called Retrophin: an intranasal formulation of
373: 170: 106: 223:
Turing Pharmaceuticals was launched in February 2015 by
145: 928:
Companies that filed for Chapter 11 bankruptcy in 2023
384:
Turing Pharmaceuticals is also working on TRP-001 for
320:, but was discontinued by Sandoz's successor company, 709:. Turingpharma.com. November 24, 2015. Archived from 562:. Turingpharma.com. February 24, 2015. Archived from 889:. Turinpharma.com. November 16, 2015. Archived from 683:. Turingpharma.com. October 13, 2015. Archived from 863:. Turingpharma.com. October 5, 2015. Archived from 588:. Turingpharma.com. August 10, 2015. Archived from 227:with the acquisition of three major assets from an 707:"Turing Reduces Cost of Daraprim® (pyrimethamine)" 658: 388:, TRP-002 for developmental disorder, TRP-003 for 184:The company has two marketed products: Daraprim ( 909: 379: 324:, in 1997 because of poor sales. Retrophin had 436:. Louisiana Secretary of State. Archived from 434:"Corporation Filings 08/27/2017 to 09/03/2017" 613:"A Timeline of the Turing Pharma Controversy" 460:"Oxytocin intranasal - Vyera Pharmaceuticals" 918:Pharmaceutical companies established in 2015 610: 364:disorders. Turing Pharmaceuticals made an 36: 506: 258:Daraprim is the trade name for the drug 923:Pharmaceutical companies of Switzerland 611:Timmermann, Like (September 23, 2015). 507:Weintraub, Arlene (February 27, 2015). 14: 910: 816: 762:: CS1 maint: archived copy as title ( 480: 640:. Theguardian.com. December 19, 2015 196:hydrochloride) for the treatment of 481:Mullin, Emily (February 27, 2015). 24: 841:. Business Wire. December 12, 2013 817:Koenig, Bryan (December 7, 2021). 25: 944: 659:Ariana Eunjung Cha (2015-09-22). 211:On May 10, 2023, Vyera filed for 879: 853: 831: 810: 790: 770: 725: 699: 673: 652: 630: 604: 578: 552: 526: 500: 474: 452: 426: 401: 13: 1: 395: 380:Other products in development 310: 218: 778:"Vyera Pharmaceuticals, LLC" 7: 305: 253: 10: 949: 386:glycogen storage disorders 355: 339: 297: 208:, the computer scientist. 70:; 9 years ago 140: 132: 116: 98: 82: 64: 54: 44: 35: 783:Federal Trade Commission 318:postpartum milk ejection 188:), for the treatment of 169:company incorporated in 126:Chief Executive Officer 413:Turing Pharmaceuticals 370:Fast Track designation 163:Turing Pharmaceuticals 27:Pharmaceutical company 18:Turing Pharmaceuticals 213:Chapter 11 bankruptcy 159:Vyera Pharmaceuticals 31:Vyera Pharmaceuticals 566:on 26 September 2015 893:on 22 December 2015 867:on 22 December 2015 806:. December 8, 2021. 786:. January 27, 2020. 713:on 22 December 2015 687:on 22 December 2015 666:The Washington Post 538:Wall Street Journal 32: 440:on 15 January 2022 241:Impax Laboratories 177:, with offices in 68:February 2015 30: 409:"Leadership Team" 156: 155: 136:Vecamyl, Daraprim 128: 16:(Redirected from 940: 903: 902: 900: 898: 883: 877: 876: 874: 872: 857: 851: 850: 848: 846: 835: 829: 828: 814: 808: 807: 794: 788: 787: 774: 768: 767: 761: 753: 751: 750: 744: 738:. Archived from 737: 729: 723: 722: 720: 718: 703: 697: 696: 694: 692: 677: 671: 670: 656: 650: 649: 647: 645: 634: 628: 627: 625: 623: 608: 602: 601: 599: 597: 582: 576: 575: 573: 571: 556: 550: 549: 547: 545: 530: 524: 523: 521: 519: 504: 498: 497: 495: 493: 478: 472: 471: 469: 467: 456: 450: 449: 447: 445: 430: 424: 423: 421: 419: 405: 243:in August 2015. 152: 149: 147: 124: 78: 76: 71: 40: 33: 29: 21: 948: 947: 943: 942: 941: 939: 938: 937: 908: 907: 906: 896: 894: 885: 884: 880: 870: 868: 859: 858: 854: 844: 842: 837: 836: 832: 815: 811: 796: 795: 791: 776: 775: 771: 755: 754: 748: 746: 742: 735: 733:"Archived copy" 731: 730: 726: 716: 714: 705: 704: 700: 690: 688: 679: 678: 674: 657: 653: 643: 641: 636: 635: 631: 621: 619: 609: 605: 595: 593: 592:on 4 March 2016 584: 583: 579: 569: 567: 558: 557: 553: 543: 541: 532: 531: 527: 517: 515: 505: 501: 491: 489: 479: 475: 465: 463: 458: 457: 453: 443: 441: 432: 431: 427: 417: 415: 407: 406: 402: 398: 382: 358: 342: 313: 308: 300: 276:Elijah Cummings 270:than Daraprim. 256: 221: 192:, and Vecamyl ( 144: 123: 122:Justin Garrett 119: 94: 74: 72: 69: 59:Pharmaceuticals 28: 23: 22: 15: 12: 11: 5: 946: 936: 935: 930: 925: 920: 905: 904: 878: 852: 830: 809: 789: 769: 724: 698: 672: 651: 629: 603: 577: 551: 540:. May 10, 2023 525: 499: 473: 451: 425: 399: 397: 394: 390:leukodystrophy 381: 378: 357: 354: 341: 338: 312: 309: 307: 304: 299: 296: 255: 252: 225:Martin Shkreli 220: 217: 202:Martin Shkreli 167:pharmaceutical 154: 153: 142: 138: 137: 134: 130: 129: 120: 117: 114: 113: 100: 96: 95: 93: 92: 90:Martin Shkreli 86: 84: 80: 79: 66: 62: 61: 56: 52: 51: 46: 42: 41: 26: 9: 6: 4: 3: 2: 945: 934: 931: 929: 926: 924: 921: 919: 916: 915: 913: 892: 888: 882: 866: 862: 856: 840: 834: 826: 825: 820: 813: 805: 804: 799: 793: 785: 784: 779: 773: 765: 759: 745:on 2016-03-20 741: 734: 728: 712: 708: 702: 686: 682: 676: 668: 667: 662: 655: 639: 633: 618: 614: 607: 591: 587: 581: 565: 561: 555: 539: 535: 529: 514: 510: 503: 488: 484: 477: 462:. AdisInsight 461: 455: 439: 435: 429: 414: 410: 404: 400: 393: 391: 387: 377: 375: 371: 367: 363: 353: 351: 347: 337: 335: 331: 330:schizophrenia 327: 323: 319: 303: 295: 293: 289: 283: 281: 277: 271: 269: 265: 261: 260:pyrimethamine 251: 248: 244: 242: 238: 234: 230: 226: 216: 214: 209: 207: 203: 199: 195: 191: 190:toxoplasmosis 187: 186:pyrimethamine 182: 180: 179:New York City 176: 172: 168: 164: 160: 151: 143: 139: 135: 131: 127: 121: 115: 112: 108: 104: 103:New York City 101: 97: 91: 88: 87: 85: 81: 67: 63: 60: 57: 53: 50: 47: 43: 39: 34: 19: 895:. Retrieved 891:the original 881: 869:. Retrieved 865:the original 855: 843:. Retrieved 833: 822: 812: 801: 792: 781: 772: 747:. Retrieved 740:the original 727: 715:. Retrieved 711:the original 701: 689:. Retrieved 685:the original 675: 664: 654: 642:. Retrieved 632: 620:. Retrieved 616: 606: 594:. Retrieved 590:the original 580: 568:. Retrieved 564:the original 554: 542:. Retrieved 537: 528: 516:. Retrieved 512: 502: 490:. Retrieved 486: 476: 466:24 September 464:. Retrieved 454: 444:24 September 442:. Retrieved 438:the original 428: 416:. Retrieved 412: 403: 383: 359: 343: 314: 301: 284: 272: 257: 249: 245: 222: 210: 198:hypertension 194:mecamylamine 183: 162: 158: 157: 99:Headquarters 45:Company type 933:Alan Turing 897:19 December 871:19 December 845:19 December 717:19 December 691:19 December 644:19 December 622:19 December 596:19 December 570:19 December 518:19 December 418:20 December 350:suicidality 264:sulfonamide 229:orphan drug 206:Alan Turing 175:Switzerland 111:Switzerland 912:Categories 749:2016-02-04 617:Forbes.com 513:Forbes.com 492:2 February 487:Forbes.com 396:References 311:Syntocinon 219:Background 161:(formerly 118:Key people 758:cite web 362:epilepsy 346:ketamine 326:licensed 322:Novartis 306:Pipeline 254:Daraprim 237:oxytocin 233:ketamine 133:Products 55:Industry 803:AP News 544:May 10, 372:by the 356:TUR-004 340:TUR-002 298:Vecamyl 288:AP News 278:to the 165:) is a 141:Website 83:Founder 75:2015-02 73: ( 65:Founded 49:Private 824:Law360 334:autism 292:Law360 148:.vyera 743:(PDF) 736:(PDF) 235:, an 899:2015 873:2015 847:2015 764:link 719:2015 693:2015 646:2015 624:2015 598:2015 572:2015 546:2023 520:2015 494:2016 468:2017 446:2017 420:2016 332:and 268:ADME 150:.com 105:and 374:FDA 366:IND 171:Zug 146:www 107:Zug 914:: 821:. 800:. 780:. 760:}} 756:{{ 663:. 615:. 536:. 511:. 485:. 411:. 352:. 215:. 173:, 109:, 901:. 875:. 849:. 827:. 766:) 752:. 721:. 695:. 669:. 648:. 626:. 600:. 574:. 548:. 522:. 496:. 470:. 448:. 422:. 77:) 20:)

Index

Turing Pharmaceuticals

Private
Pharmaceuticals
Martin Shkreli
New York City
Zug
Switzerland
Chief Executive Officer
www.vyera.com
pharmaceutical
Zug
Switzerland
New York City
pyrimethamine
toxoplasmosis
mecamylamine
hypertension
Martin Shkreli
Alan Turing
Chapter 11 bankruptcy
Martin Shkreli
orphan drug
ketamine
oxytocin
Impax Laboratories
pyrimethamine
sulfonamide
ADME
Elijah Cummings

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.

↑